BrainStorm Cell Therapeutics
BCLI
#10978
Rank
A$12.86 M
Marketcap
A$1.17
Share price
5.13%
Change (1 day)
10.45%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -A$15.47 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$14.66 Million, an increase over its 2024 earnings that were of -A$16.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$15.47 Million5.56%
2025 -A$14.66 Million-11.32%
2024 -A$16.53 Million-32.39%
2023 -A$24.45 Million-29.18%
2022 -A$34.52 Million-0.74%
2021 -A$34.78 Million-23.12%
2020 -A$45.23 Million36.8%
2019 -A$33.07 Million66.71%
2018 -A$19.84 Million181.66%
2017 -A$7.05 Million-0.6%
2016 -A$7.09 Million-41.31%
2015 -A$12.07 Million-8.22%
2014 -A$13.15 Million89.74%
2013 -A$6.93 Million42.27%
2012 -A$4.88 Million-12.45%
2011 -A$5.57 Million63.04%
2010 -A$3.42 Million35.52%
2009 -A$2.52 Million-48.99%
2008 -A$4.94 Million-44.39%
2007 -A$8.88 Million
2005 -A$4.6 Million-91.44%
2004 -A$53.72 Million94007.62%
2003 -A$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$1.43 B-9,712.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.78 Billion 18,480.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.13 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.28 Billion 8,396.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.21 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.37 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA